Prostatic cancer with rhabdomyolysis resulting from LH-RH agonist administration

I. Morita, S. Kaji, K. Tatsugami, T. Sumii

Research output: Contribution to journalArticlepeer-review


An 86-year-old patient with advanced prostatic cancer who was treated with LH-RH agonist (Leuplin 3.75 mg) developed fever, malaise, fatigability and anuria 13 days after the treatment. Rhabdomyolysis was suggested by laboratory data (GOT, LDH, Mb, Aldolase, CPK). There was no predisposing factor other than LH-RH agonist as the cause of drug-induced rhabdomyolysis.

Original languageEnglish
Pages (from-to)149-151
Number of pages3
JournalIRYO - Japanese Journal of National Medical Services
Issue number2
Publication statusPublished - 1996
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'Prostatic cancer with rhabdomyolysis resulting from LH-RH agonist administration'. Together they form a unique fingerprint.

Cite this